Imperial College London

Professor Molly Stevens

Faculty of EngineeringDepartment of Materials

Prof of Biomedical Materials&Regenerative Medicine



+44 (0)20 7594 6804m.stevens




208Royal School of MinesSouth Kensington Campus






BibTex format

author = {Armstrong, J and Stevens, M},
doi = {10.1089/ten.tea.2019.0026},
journal = {Tissue Engineering: Parts A, B, and C},
title = {Emerging technologies for tissue engineering: from gene editing to personalized medicine},
url = {},
volume = {25},
year = {2019}

RIS format (EndNote, RefMan)

AB - Technological innovation has been integral to the development of tissue engineering over the last 25 years. Future advances will require the next-generation of tissue engineers to embrace emerging technologies. Here, we discuss four key areas of opportunity in which technology can play a role: biological manipulation, advanced characterization, process automation and personalized medicine. This encompasses key developments in transdifferentiation, gene editing, spatially-resolved -omics and 3D bioprinting. Taken together, we can imagine an idealized future in which computational predictions made by machine learning algorithms are used to programme cells and materials to create personalized tissue constructs within an automated culture system.
AU - Armstrong,J
AU - Stevens,M
DO - 10.1089/ten.tea.2019.0026
PY - 2019///
SN - 1937-3341
TI - Emerging technologies for tissue engineering: from gene editing to personalized medicine
T2 - Tissue Engineering: Parts A, B, and C
UR -
UR -
VL - 25
ER -